32 reports

  • 6.1 INTRODUCTION
  • FUNCTIONAL FOOD INGREDIENTS MARKET SIZE, BY TYPE, 2016-2023 (USD MILLION)

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Mineral Supplement
  • United States
  • Market Size
  • Arla Foods
  • Cargill Inc.

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

THE MICROPEARLS SPRAY FREEZING TECHNOLOGY ALLOWS FOR THE TIMELY RELEASE OF THESE ## KEY NUTRIENTS THROUGHOUT AN ANIMAL' S GASTROINTESTINAL TRACT.

  • Mineral Supplement
  • North America
  • United States
  • World
  • Market Size
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

By the year 2040, ## adult in ## will have diabetes.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.
  • Pipeline analysis

Sotagliflozin is a small molecule and exhibits its mechanism by inhibiting SGLT-##, which helps absorb glucose and galactose in the gastrointestinal (GI) tract, and SGLT-##, which helps in glucose reabsorption by the kidney.

  • Type 1 Diabetes
  • World
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Mineral Supplement
  • North America
  • United States
  • Demand
  • Market Size

Q. ##.

  • Mineral Supplement
  • United States
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • Nutreco N.V.

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group
  • Mar 26, 2018: Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults with Type 1 Diabetes
  • 06/05/2017: Lexicon Pharmaceuticals To Present New Clinical Data At 77th American Diabetes Association Scientific Sessions

Most carcinoid tumors are found in the gastrointestinal tract.

  • Mineral Supplement
  • Pharmaceutical
  • Type 1 Diabetes
  • United States
  • Lexicon Pharmaceuticals, Inc.
  • SYNTHETIC PEPTIDE TO AGONIZE NK1 FOR TYPE 1 DIABETES - DRUG PROFILE
  • COMPUGEN LTD

Its pipeline candidates are used to treat the gastrointestinal and CRC and orphan diseases.

  • Chronic Disease
  • Mineral Supplement
  • Type 1 Diabetes
  • United States
  • Company

NIHS' research categories comprise brain health, molecular nutrition, system science, cell biology, mitochondrial function, omics, informatics, cognitive health and ageing, metabolic health, and gastrointestinal health.

  • Cell Therapy
  • Type 1 Diabetes
  • United States
  • Company Operations
  • ViaCyte, Inc.

Early in January 2018, Adocia had also announced the expansion of the BioChaperone technology platform to enable the development of innovative treatments in the gastrointestinal (BioChaperone GLP-##) and obesity (BioChaperone Glucagon GLP-##) fields.

  • Insulin
  • Type 1 Diabetes
  • United States
  • Company
  • Adocia

The Minimally Invasive Therapies Group (MITG) includes the Surgical Innovations (SI) and the Respiratory, Gastrointestinal & Renal (RGR) divisions.

  • Clinical Trial
  • Endocrine Disease
  • Insulin Delivery
  • Type 1 Diabetes
  • Medtronic, Inc.

The prominent features of this report are - ##.

  • Mineral Supplement
  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative

The molecules developed by companies in Phase III, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Shenogen Pharma Group
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Mineral Supplement
  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY REGIMMUNE CORPORATION, H2 2016
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY CARLINA TECHNOLOGIES SAS, H2 2016

It discovers, develops and commercializes medicines for gastrointestinal disorders.

  • Biotech
  • Mineral Supplement
  • Type 1 Diabetes
  • Company
  • Product Initiative
  • Type 1 Diabetes
  • Telotristatetiprate (LX1032)

SGLT## is a transporter responsible for glucose and galactose absorption in the gastrointestinal tract.

  • Clinical Trial
  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • Type 1 Diabetes
  • PIPELINE BY GLAXOSMITHKLINE PLC, H1 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Glycoprotein
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Xencor, Inc.
  • Mar 08, 2018: Unique inflammation patterns emerging in patients with type 1 diabetes

Potential applications include hearing loss, skin disorders and gastrointestinal diseases.

  • Insulin
  • Mineral Supplement
  • Type 1 Diabetes
  • United States
  • Sernova Corp.